ABSTRACT
BACKGROUND: Recent studies on the association between Helicobacter pylori (H. pylori) infection and obesity have reported conflicting results. Therefore, the purpose of our study was to investigate the association of obesity, abdominal obesity, and metabolic obesity phenotypes with H. pylori infection. METHODS: A cross-sectional study of 1568 participants aged 20 to 85 was conducted using the National Health and Nutrition Examination Survey (NHANES) cycle 1999-2000. Logistic regression models were employed to evaluate the association of general obesity as defined by body mass index (BMI), abdominal obesity as defined by waist circumference (WC) and waist-height ratio (WHtR), and metabolic obesity phenotypes with H. pylori seropositivity. Subgroup analyses stratified by age were conducted to explore age-specific differences in this association. RESULTS: After grouping individuals according to their WHtR, the prevalence rate of WHtR ≥ 0.5 in H. pylori-seropositive participants was significantly higher than that in H. pylori-seronegative participants (79.75 vs. 68.39, P < 0.001). The prevalence of H. pylori seropositivity in non-abdominal obesity and abdominal obesity defined by WHtR was 24.97% and 31.80%, respectively (P < 0.001). In the subgroup analysis, the adjusted association between abdominal obesity, as defined by the WHtR, and H. pylori seropositivity was significant in subjects aged < 50 years (OR = 2.23; 95% CI, 1.24-4.01; P = 0.01) but not in subjects aged ≥ 50 years (OR = 0.84; 95% CI, 0.35-1.99; P = 0.66). Subjects older than 50 years old had an OR (95% CI) for metabolically healthy obesity of 0.04 (0.01-0.35) compared with the control group. H. pylori seropositivity was consistently not associated with obesity as defined by BMI. CONCLUSIONS: Abdominal obesity, as defined by the WHtR, was associated with H. pylori infection in subjects aged ≤ 50 years.
Subject(s)
Helicobacter Infections , Helicobacter pylori , Nutrition Surveys , Obesity, Abdominal , Obesity , Humans , Helicobacter Infections/epidemiology , Helicobacter Infections/microbiology , Helicobacter Infections/complications , Middle Aged , Adult , Male , Female , Cross-Sectional Studies , Aged , Obesity/microbiology , Obesity/epidemiology , Aged, 80 and over , Young Adult , Obesity, Abdominal/epidemiology , Obesity, Abdominal/microbiology , Prevalence , Phenotype , Body Mass IndexABSTRACT
Obesity, especially central obesity, is a strong risk factor for developing type 2 diabetes (T2D). However, the mechanism underlying the progression from central obesity to T2D remains unknown. Therefore, we analyzed the gut microbial profiles of central obese individuals with or without T2D from a Chinese population. Here we reported both the microbial compositional and gene functional alterations during the progression from central obesity to T2D. Several opportunistic pathogens were enriched in obese T2D patients. We also characterized thousands of genes involved in sugar and amino acid metabolism whose abundance were significantly depleted in obese T2D group. Moreover, the abundance of those genes was negatively associated with plasma glycemia level and percentage of individuals with impaired plasma glucose status. Therefore, our study indicates that the abundance of those depleted genes can be used as a potential biomarker to identify central obese individuals with high risks of developing T2D.
Subject(s)
Carbohydrate Metabolism/genetics , Diabetes Mellitus, Type 2/etiology , Gastrointestinal Microbiome/genetics , Obesity, Abdominal/microbiology , Adult , Biomarkers/metabolism , Case-Control Studies , China , Diabetes Mellitus, Type 2/genetics , Diabetes Mellitus, Type 2/metabolism , Diabetes Mellitus, Type 2/microbiology , Disease Progression , Disease Susceptibility , Female , Humans , Male , Metagenome/physiology , Obesity, Abdominal/genetics , Obesity, Abdominal/metabolism , Obesity, Abdominal/pathology , RNA, Ribosomal, 16S/analysis , RNA, Ribosomal, 16S/genetics , Risk Factors , TranscriptomeABSTRACT
BACKGROUND: Although recent studies have revealed an association between the composition of the gut microbiota and obesity, whether specific gut microbiota cause obesity has not been determined. OBJECTIVES: The aim of this study is to determine the causal relationship between specific gut microbiota and abdominal obesity. Based on genome-wide association study (GWAS) summary statistics, we performed a 2-sample Mendelian randomization (MR) analysis to evaluate whether the gut microbiota affects abdominal obesity. METHODS: Gut microbiota GWAS in 1126 twin pairs (age range, 18-89 years; 89% were females) from the TwinsUK study were used as exposure data. The primary outcome tested was trunk fat mass (TFM) GWAS in 492,805 participants (age range, 40-69 years; 54% were females) from the UK Biobank. The gut microbiota were classified at family, genus, and species levels. A feature was defined as a distinct family, genus, or species. MR analysis was mainly performed by an inverse variance-weighted test or Wald ratio test, depending on the number of instrumental variables (IVs) involved. A sensitivity analysis was performed on significant results by a weighted median test and a weighted genetic risk score (GRS) analysis. RESULTS: Results of MR analyses provided evidence of a causal association between 3 microbiota features and TFM, including 1 family [Lachnosiraceae; P = 0.02; ß = 0.001 (SEE, 4.28 × 10-4)], 1 genus [Bifidobacterium; P = 5.0 × 10-9; ß = -0.08 (SEE, 0.14)], and 1 species [Prausnitzii; P = 0.03; ß = -0.007 (SEE, 0.003)]. Both the weighted median test and GRS analysis successfully validated the association of the genetically predicted family, Lachnosiraceae (Pweighted median = 0.03; PGRS = 0.004). CONCLUSIONS: Our findings provided evidence of a causal association between gut microbiota and TFM in UK adults and identified specific bacteria taxa that may regulate the fat metabolism, thus offering new direction for the treatment of obesity.
Subject(s)
Gastrointestinal Microbiome , Mendelian Randomization Analysis , Obesity, Abdominal , Adolescent , Adult , Aged , Aged, 80 and over , Female , Genome-Wide Association Study , Humans , Male , Middle Aged , Obesity, Abdominal/genetics , Obesity, Abdominal/microbiology , Young AdultABSTRACT
CONTEXT: Intermittent fasting (IF) is an effective strategy to improve cardiometabolic health. OBJECTIVE: The objective of this work is to examine the effects of IF on cardiometabolic risk factors and the gut microbiota in patients with metabolic syndrome (MS). DESIGN AND SETTING: A randomized clinical trial was conducted at a community health service center. PATIENTS: Participants included adults with MS, age 30 to 50 years. INTERVENTION: Intervention consisted of 8 weeks of "2-day" modified IF. MAIN OUTCOME MEASURE: Cardiometabolic risk factors including body composition, oxidative stress, inflammatory cytokines, and endothelial function were assessed at baseline and at 8 weeks. The diversity, composition, and functional pathways of the gut microbiota, as well as circulating gut-derived metabolites, were measured. RESULTS: Thirty-nine patients with MS were included: 21 in the IF group and 18 in the control group. On fasting days, participants in the IF group reduced 69% of their calorie intake compared to nonfasting days. The 8-week IF significantly reduced fat mass, ameliorated oxidative stress, modulated inflammatory cytokines, and improved vasodilatory parameters. Furthermore, IF induced significant changes in gut microbiota communities, increased the production of short-chain fatty acids, and decreased the circulating levels of lipopolysaccharides. The gut microbiota alteration attributed to the IF was significantly associated with cardiovascular risk factors and resulted in distinct genetic shifts of carbohydrate metabolism in the gut community. CONCLUSION: IF induces a significant alteration of the gut microbial community and functional pathways in a manner closely associated with the mitigation of cardiometabolic risk factors. The study provides potential mechanistic insights into the prevention of adverse outcomes associated with MS.
Subject(s)
Cardiometabolic Risk Factors , Fasting/physiology , Gastrointestinal Microbiome , Metabolic Syndrome/diet therapy , Adult , Body Composition , Caloric Restriction/methods , Cardiovascular Diseases/etiology , Cardiovascular Diseases/prevention & control , China , Dysbiosis/etiology , Dysbiosis/prevention & control , Female , Gastrointestinal Microbiome/physiology , Humans , Male , Metabolic Syndrome/complications , Metabolic Syndrome/metabolism , Metabolic Syndrome/microbiology , Middle Aged , Obesity, Abdominal/complications , Obesity, Abdominal/diet therapy , Obesity, Abdominal/metabolism , Obesity, Abdominal/microbiology , Treatment OutcomeABSTRACT
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is common among people living with HIV. There are limited data available on the pathophysiology of NAFLD and the development of fibrosis in this population. OBJECTIVES: The aim of this study was to investigate the association of bacterial translocation, adipose tissue dysfunction, monocyte activation and gut dysbiosis in patients with HIV monoinfection and NAFLD. METHODS: Cases with biopsy-proven NAFLD and HIV monoinfection were age and sex-matched to HIV-positive and HIV-negative controls. Markers of bacterial translocation [lipopolysaccharide-binding protein (LBP), bacterial DNA and lipopolysaccharide (LPS)], adipose tissue dysfunction (leptin, adiponectin) and monocyte activation (sCD14 and sCD163) were measured by ELISA. Hepatic patterns of macrophage activation were explored with immunohistochemistry. 16âs rRNA sequencing was performed with stool. RESULTS: Thirty-three cases were included (≥F2 fibrosis nâ=â16), matched to HIV-positive (nâ=â29) and HIV-negative (nâ=â17) controls. Cases with NAFLD were more obese (BMI 31.0â±â4.4 vs. 24.1â±â2.8âkg/m, Pâ<â0.001) and had significantly increased levels of sCD14, sCD163 and higher leptin to adiponectin ratio vs. HIV-positive controls. Cases with ≥F2 versesâ<âF2 fibrosis had increased sCD14 (1.4â±â0.4 vs. 1.1â±â0.3âµg/ml, Pâ=â0.023) and sCD163 (1.0â±â0.3 vs. 0.8â±â0.3âµg/ml, Pâ=â0.060), which correlated with waist circumference (sCD14 Pâ=â0.022, sCD163 Pâ=â0.011). Immunohistochemistry showed increased hepatic portal macrophage clusters in patients with fibrosis. No markers of bacterial translocation or changes to the microbiome were associated with NAFLD or fibrosis. CONCLUSION: NAFLD fibrosis stage in HIV monoinfected patients is associated with monocyte activation in the context of obesity, which may be independent of bacterial translocation and gut microbiome.
Subject(s)
Bacterial Translocation/physiology , Bacteroidaceae Infections/pathology , Gastrointestinal Microbiome/immunology , HIV Seropositivity/immunology , Liver Cirrhosis/pathology , Macrophage Activation/physiology , Non-alcoholic Fatty Liver Disease/pathology , Obesity, Abdominal/immunology , Adult , Bacteroidaceae Infections/immunology , Dysbiosis/virology , Feces/microbiology , Female , HIV Seropositivity/physiopathology , Humans , Immunohistochemistry , Liver/pathology , Liver Cirrhosis/immunology , Liver Cirrhosis/microbiology , Male , Middle Aged , Non-alcoholic Fatty Liver Disease/immunology , Non-alcoholic Fatty Liver Disease/microbiology , Obesity, Abdominal/microbiology , Prevotella/isolation & purification , Prospective Studies , RNA, Ribosomal, 16S , United KingdomABSTRACT
Late-onset hypogonadism (i.e. androgen deficiency) raises the risk for abdominal obesity in men. The mechanism for this obesity is unclear. Here, we demonstrated that hypogonadism after castration caused abdominal obesity in high-fat diet (HFD)-fed, but not in standard diet (SD)-fed, C57BL/6J mice. Furthermore, the phenotype was not induced in mice treated with antibiotics that disrupt the intestinal microflora. In HFD-fed mice, castration increased feed efficiency and decreased fecal weight per food intake. Castration also induced in an increase of visceral fat mass only in the absence of antibiotics in HFD-fed mice, whereas subcutaneous fat mass was increased by castration irrespective of antibiotics. Castration reduced the expression in the mesenteric fat of both adipose triglyceride lipase and hormone-sensitive lipase in HFD-fed mice, which was not observed in the presence of antibiotics. Castration decreased thigh muscle (i.e. quadriceps and hamstrings) mass, elevated fasting blood glucose levels, and increased liver triglyceride levels in a HFD-dependent manner, whereas these changes were not observed in castrated mice treated with antibiotics. The Firmicutes/Bacteroidetes ratio and Lactobacillus species increased in the feces of HFD-fed castrated mice. These results show that androgen (e.g. testosterone) deficiency can alter the intestinal microbiome and induce abdominal obesity in a diet-dependent manner.
Subject(s)
Androgens/metabolism , Gastrointestinal Microbiome/drug effects , Hypogonadism/physiopathology , Obesity, Abdominal/genetics , Adipose Tissue/growth & development , Adipose Tissue/microbiology , Adipose Tissue/physiopathology , Androgens/deficiency , Animals , Anti-Bacterial Agents/administration & dosage , Blood Glucose , Castration/adverse effects , Diet, High-Fat , Gene Expression Regulation, Enzymologic/drug effects , Humans , Hypogonadism/etiology , Hypogonadism/microbiology , Lipase/biosynthesis , Male , Mice , Obesity, Abdominal/etiology , Obesity, Abdominal/microbiologyABSTRACT
Some studies have indicated that promoting the Mediterranean diet pattern as a model of healthy eating may help to prevent weight gain and the development of overweight/obesity. Bread consumption, which has been part of the traditional Mediterranean diet, has continued to decline in Spain and in the rest of the world, because the opinion of the general public is that bread fattens. The present study was conducted to assess whether or not eating patterns that include bread are associated with obesity and excess abdominal adiposity, both in the population at large or in subjects undergoing obesity management. The results of the present review indicate that reducing white bread, but not whole-grain bread, consumption within a Mediterranean-style food pattern setting is associated with lower gains in weight and abdominal fat. It appears that the different composition between whole-grain bread and white bread varies in its effect on body weight and abdominal fat. However, the term 'whole-grain bread' needs to be defined for use in epidemiological studies. Finally, additional studies employing traditional ways of bread production should analyse this effect on body-weight and metabolic regulation.
Subject(s)
Bread/adverse effects , Diet, Mediterranean , Dietary Fiber/therapeutic use , Evidence-Based Medicine , Food Handling , Nutrition Policy , Obesity/prevention & control , Abdominal Fat/pathology , Adiposity , Animals , Bread/analysis , Bread/standards , Diet, Mediterranean/adverse effects , Dietary Fiber/analysis , Energy Intake , Glycemic Index , Humans , Intestines/growth & development , Intestines/microbiology , Obesity/etiology , Obesity/microbiology , Obesity/pathology , Obesity, Abdominal/etiology , Obesity, Abdominal/microbiology , Obesity, Abdominal/pathology , Obesity, Abdominal/prevention & control , Terminology as Topic , Weight GainABSTRACT
OBJECTIVE: To investigate the efficacy mechanisme of chicory extract interventing abdominal obesity rat from the aspect of gut bacteria. METHOD: Male SD rats were randomly divided into five groups, namely the normal group, model group, large and small dose group of chicory and the fenofibrate group. Normal group was given deionized water, the other group was given fructose water and give the medical treatment of chicory and fenofibrate. Assay triglycerides, total cholesterol, LDL and HDL by biochemical methods and measure body weight and abdominal circumference and microscopicly observe the count changes of gut bacteria through real-time PCR method. RESULT: Compared with normal group, the triglyceride level and abdominal circumference were significantly higher (P < 0.05), weight and high-density lipoprotein increased but no significant changes and E. coli, lactobacillus increased significantly. Compared with model group, chicory extract large and small dose group and the fenofibrate group can significantly reduce triglyceride levels (P < 0.05), reduce the number of E. coli and Lactobacillus and increase the number of bifidobacteria. The fenofibrate group can significantly reduce total cholesterol and high-density lipoprotein levels. CONCLUSION: The chicory's treatment effect on abdominal obesity is significant. The efficacy mechanisme intervention abdominal obesity may be related to the reduction of the number of lactic acid bacteria and E. coli and the increase of bifidobacteria.
Subject(s)
Bacteria/isolation & purification , Cichorium intybus/metabolism , Gastrointestinal Tract/microbiology , Microbiota , Obesity, Abdominal/metabolism , Obesity, Abdominal/microbiology , Plant Extracts/metabolism , Animals , Bacteria/classification , Bacteria/genetics , Biodiversity , Cichorium intybus/chemistry , Cholesterol/metabolism , Humans , Male , Rats , Rats, Sprague-Dawley , Triglycerides/metabolismABSTRACT
OBJECTIVE: It is of vital importance to elucidate the triggering factors of obesity and type 2 diabetes to improve patient care. Bariatric surgery has been shown to prevent and even cure diabetes, but the mechanism is unknown. Elevated levels of lipopolysaccharide (LPS) predict incident diabetes, but the sources of LPS are not clarified. The objective of the current study was to evaluate the potential impact of plasma LPS on abdominal obesity and glycemic control in subjects undergoing bariatric surgery. RESEARCH DESIGN AND METHODS: This was a prospective observational study involving a consecutive sample of 49 obese subjects undergoing bariatric surgery and 17 controls. Main assessments were plasma LPS, HbA1c, adipose tissue volumes (computed tomography), and quantified bacterial DNA in adipose tissue compartments. RESULTS: Plasma levels of LPS were elevated in obese individuals compared with controls (P < 0.001) and were reduced after bariatric surgery (P = 0.010). LPS levels were closely correlated with HbA1c (r = 0.56; P = 0.001) and intra-abdominal fat volumes (r = 0.61; P < 0.001), but only moderately correlated with subcutaneous fat volumes (r = 0.33; P = 0.038). Moreover, there was a decreasing gradient (twofold) in bacterial DNA levels going from mesenteric via omental to subcutaneous adipose tissue compartments (P = 0.041). Finally, reduced LPS levels after bariatric surgery were directly correlated with a reduction in HbA1c (r = 0.85; P < 0.001). CONCLUSIONS: Our findings support a hypothesis of translocated gut bacteria as a potential trigger of obesity and diabetes, and suggest that the antidiabetic effects of bariatric surgery might be mechanistically linked to, and even the result of, a reduction in plasma levels of LPS.
Subject(s)
Bariatric Surgery , Blood Glucose , Lipopolysaccharides/blood , Obesity, Abdominal/microbiology , Obesity, Abdominal/surgery , Adult , DNA, Bacterial/analysis , Diabetes Mellitus, Type 2/microbiology , Diabetes Mellitus, Type 2/prevention & control , Female , Glycated Hemoglobin/analysis , Humans , Intra-Abdominal Fat/diagnostic imaging , Intra-Abdominal Fat/microbiology , Intra-Abdominal Fat/surgery , Lipopolysaccharide Receptors/blood , Male , Middle Aged , Obesity, Abdominal/blood , Omentum/microbiology , Omentum/surgery , Prospective Studies , Subcutaneous Fat/diagnostic imaging , Subcutaneous Fat/microbiology , Subcutaneous Fat/surgery , Tomography, X-Ray ComputedABSTRACT
The gut microbiome interacts with the host in the metabolic response to diet, and early microbial aberrancies may be linked to the development of obesity and metabolic disorders later in life. Probiotics have been proposed to affect metabolic programming and blood lipid levels, although studies are lacking in infants. Here, we report on the lipid profile and global metabolic response following daily feeding of probiotics during weaning. A total of 179 healthy, term infants were randomised to daily intake of cereals with (n 89) or without (n 90) the addition of Lactobacillus paracasei ssp. paracasei F19 (LF19) 108 colony-forming units per serving from 4 to 13 months of age. Weight, length and skinfold thickness were monitored. Venous blood was drawn at 5·5 and 13 months of age for analysis of the serum lipid profile. In a subsample, randomly selected from each group, GC-time-of-flight/MS was used to metabolically characterise plasma samples from thirty-seven infants. A combination of multi- and univariate analysis was applied to reveal differences related to LF19 treatment based on 228 putative metabolites, of which ninety-nine were identified or classified. We observed no effects of probiotic feeding on anthropometrics or the serum lipid profile. However, we detected significantly lower levels of palmitoleic acid (16 : 1) (P< 0·05) and significantly higher levels of putrescine (P< 0·01) in LF19-treated infants. Palmitoleic acid is a major MUFA strongly linked to visceral obesity, while putrescine is a polyamine with importance for gut integrity. Whether the observed differences will have long-term health consequences are being followed.